Pancreatic Cancer Research

ResearcherUniversity of BonnActive in the last 2 years

Tim R. Glowka

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6996-9766; OpenAlex author ID A5011005301. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
36
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 2 papers · 2025: none · 2026: 1 paper

Papers 7

  1. R0 Resection improves survival after multivisceral resection for pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.isci.2026.117352↗
  2. A retrospective, multicentric, nationwide analysis of the impact of splenectomy on survival of pancreatic cancer patients. Co-author DOI 10.1007/s00423-024-03570-y↗
  3. Study Protocol of a Randomized, Two-Arm, Phase I/II Trial Investigating the Feasibility, Safety, and Efficacy of Local Treatment with US-Guided High-Intensity … Co-author DOI 10.3390/jcm13133717↗
  4. Second-line and third-line therapy with nanoliposomal irinotecan (nal-IRI) in pancreatic cancer: a single-center experience and review of literature. Co-author DOI 10.21037/jgo-22-632↗
  5. Delayed Gastric Emptying Does Not Influence Cancer-Specific Survival after Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/jcm11144200↗
  6. Fibroblast growth factor receptor 1 gene amplification in pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/his.12115↗
  7. Association of socio-economic status and stage of pancreatic cancer at time of surgery in a German setting. Co-author DOI 10.5754/hge10334↗

Closest collaborators

The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Christian Möhring · 2 shared papers, 2023–2024 · strength 0.32
  2. Milka Marinova · 2 shared papers, 2023–2024 · strength 0.32
  3. Georg Feldmann · 2 shared papers, 2023–2024 · strength 0.32
  4. Maria Angeles Gonzalez-Carmona · 2 shared papers, 2023–2024 · strength 0.32
  5. Christiane Pillny · 1 shared paper, 2022 · strength 0.19
  6. Ingo G.H. Schmidt‐Wolf · 1 shared paper, 2024 · strength 0.15
  7. Marcus O. Thudium · 1 shared paper, 2024 · strength 0.15
  8. Holger M. Strunk · 1 shared paper, 2024 · strength 0.15
  9. Marc Eric Martignoni · 1 shared paper, 2024 · strength 0.14
  10. Werner Hartwig · 1 shared paper, 2024 · strength 0.14
  11. Tobias Keck · 1 shared paper, 2024 · strength 0.14
  12. Michael B. Ghadimi · 1 shared paper, 2024 · strength 0.14
  13. Maximilian Kießler · 1 shared paper, 2024 · strength 0.14
  14. Rüdiger Göß · 1 shared paper, 2024 · strength 0.14
  15. Ilaria Pergolini · 1 shared paper, 2024 · strength 0.14
  16. Soeren Torge Mees · 1 shared paper, 2024 · strength 0.14
  17. Karl J. Oldhafer · 1 shared paper, 2024 · strength 0.14
  18. Stephan Schorn · 1 shared paper, 2024 · strength 0.14
  19. Waldemar H. Uhl · 1 shared paper, 2024 · strength 0.14
  20. Alexander Novotny · 1 shared paper, 2024 · strength 0.14
  21. Detlef Klaus Bartsch · 1 shared paper, 2024 · strength 0.14
  22. Christoph Reißfelder · 1 shared paper, 2024 · strength 0.14
  23. Carmen Mota Reyes · 1 shared paper, 2024 · strength 0.14
  24. Helmut Friess · 1 shared paper, 2024 · strength 0.14
  25. Okan Safak · 1 shared paper, 2024 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.